Windtree TherapeuticsWINT
13F holders, Q2 2025 (June 30)5holders
1new positions
1sold out
$0.52avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Windtree Therapeutics Inc. (WINT) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Jane Street Group, LLC ($8K), Tower Research Capital LLC (TRC) ($1K) and Bank of America Corp. ($53).
- Company
- Windtree Therapeutics Inc.
- CUSIP
- 97382D600
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8K |
| Exits | 1 | $19K |
All 13F filers, Q1 2025 → Q2 2025: 15,438 shares bought and 43,743 shares sold, net −28,305 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Jane Street Group, LLC | 0.00% | New | 14,599 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +60.8% | 2,212 | $1K |
| Bank of America Corp. | 0.00% | Add +3.0% | 103 | $53 |
| SBI Securities Co., Ltd. | 0.00% | No change | 24 | $12 |
| UBS Group AG | 0.00% | Reduce -99.9% | 22 | $11 |
"% of holder's portfolio" is WINT's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.